BMS hires Roche's Mike Burgess
This article was originally published in Scrip
Bristol-Myers Squibb has appointed Roche's Mike Burgess senior vice-president of discovery medicine and clinical pharmacology. Prior to joining BMS Mr Burgess served as interim head of research and early development at Roche – a position now occupied by John Reed (scripintellignce.com, 16 January 2013). In his new role, Mr Burgess will report to Francis Cuss, senior vice-president research, R&D, and will be a member of BMS' research senior leadership team.
You may also be interested in...
A rush in the 2010s of high-tech and digital companies focused on women’s health and wellbeing are maturing, adding weight to the more traditional women's health market that has struggled to get attention from investors in the past.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
A selection of articles you might have missed from September 2020, including exclusive interviews with industry leaders and a review of value-based contract approaches in the US.